The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis

por Dupuy, Sheena L., Tauhid, Shahamat, Hurwitz, Shelley, Chu, Renxin, Yousuf, Fawad, Bakshi, Rohit
Publicado 2016

An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis

por Kim, Gloria, Tauhid, Shahamat, Dupuy, Sheena L., Tummala, Subhash, Khalid, Fariha, Healy, Brian C., Bakshi, Rohit
Publicado 2016

The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis

por Dupuy, Sheena L., Khalid, Fariha, Healy, Brian C., Bakshi, Sonya, Neema, Mohit, Tauhid, Shahamat, Bakshi, Rohit
Publicado 2016

The Effect of Fingolimod on Conversion of Acute Gadolinium‐Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis

por Oommen, Vinit V., Tauhid, Shahamat, Healy, Brian C., Chua, Alicia S., Malik, Muhammad T., Diaz‐Cruz, Camilo, Dupuy, Sheena L., Weiner, Howard L., Chitnis, Tanuja, Bakshi, Rohit
Publicado 2015

Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors

por Dell’Oglio, Elisa, Ceccarelli, Antonia, Glanz, Bonnie I, Healy, Brian C, Tauhid, Shahamat, Arora, Ashish, Saravanan, Nikila, Bruha, Matthew J, Vartanian, Alexander V, Dupuy, Sheena L, Benedict, Ralph HB, Bakshi, Rohit, Neema, Mohit
Publicado 2015